薬物乱用検査の世界市場予測・分析:製品別・地域別

◆英語タイトル:Drugs of Abuse Testing Market by Product and Geography - Global Forecast and Analysis 2019-2023
◆商品コード:IRTNTR31422
◆発行会社(リサーチ会社):Technavio
◆発行日:2019年6月19日
◆ページ数:118
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、米州、アジア太平洋、EMEA(ヨーロッパ・中東・アフリカ)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、薬物乱用検査の世界市場について調べ、薬物乱用検査の市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、薬物乱用検査の市場規模をセグメンテーション別(製品別(器具、消耗品))と地域別(グローバル、米州、アジア太平洋、EMEA(ヨーロッパ・中東・アフリカ))に分けて算出しました。
・サマリー
・レポートの範囲
・薬物乱用検査の市場状況
・薬物乱用検査の市場規模
・薬物乱用検査の市場予測
・薬物乱用検査の世界環境:ファイブフォース分析
・市場セグメンテーション:製品別(器具、消耗品)
・薬物乱用検査の顧客状況
・主要地域別市場規模:グローバル、米州、アジア太平洋、EMEA(ヨーロッパ・中東・アフリカ)
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...
【レポートの概要】

About this market

The growing instances of drug abuse are compelling various governments agencies such as the US FDA, the CDC, and the Drug Enforcement Agency (DEA) impose stringent regulations pertaining to the use of drugs. Implementation of these regulations is driving the growth of the global drugs of abuse testing market. For instance, the researchers in the US are required to get approval from several organizations such as the National Institute on Drug Abuse (NIDA), the US FDA, and the DEA to procure cannabis for their research purposes. Additionally, researchers must secure additional approvals from various state government departments where the research is being conducted. These factors are expected to drive the growth of the market at a CAGR of nearly 6% during 2019-2023.

Market Overview

Increased strategic developments

Vendors in the market are focusing on improving their product offerings and innovations to expand their product portfolios and ensure the availability of drugs of abuse testing to end-users such as research laboratories and academic institutions. Other strategic developments such as new product launches, joint ventures, collaborations, investments, and partnerships, and acquisitions adopted by the vendors are expected to fuel the growth of the global drugs of abuse testing market size during the forecast period.

Manipulation of drug screening tests

There are instances of people evading tests for illicit drugs by manipulating the specimen that was supposed to be subjected to the tests. For example, the easy availability of chemicals such as laundry detergent, table salt, and toilet bowl cleaners give people the liberty to adulterate the specimens to manipulate drug screening tests. This is expected to hinder the growth of the global drugs of abuse testing market size.

For the detailed list of factors that will drive and challenge the growth of the drugs of abuse testing market size during 2019-2023, view our report.

Competitive Landscape

The market appears to be fairly concentrated with few players occupying the market share. Companies such as Abbott and Bio-Rad Laboratories Inc. have intensified competition. Factors such as stringent regulatory control on the procurement of cannabis and increased strategic developments will provide significant growth opportunities for drugs of abuse testing companies. Abbott, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd, and Thermo Fisher Scientific Inc. are some of the major companies covered in this report.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product

Comparison by product

Instruments – Market size and forecast 2018-2023

Consumables – Market size and forecast 2018-2023

Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

Overview

Landscape disruption

PART 13: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Abbott

Bio-Rad Laboratories Inc.

Danaher Corp.

F. Hoffmann-La Roche Ltd

Thermo Fisher Scientific Inc.

PART 14: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

Exhibit 01: Global healthcare market

Exhibit 02: Segments of global healthcare market

Exhibit 03: Market characteristics

Exhibit 04: Market segments

Exhibit 05: Market definition – Inclusions and exclusions checklist

Exhibit 06: Market size 2018

Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 09: Five forces analysis 2018

Exhibit 10: Five forces analysis 2023

Exhibit 11: Bargaining power of buyers

Exhibit 12: Bargaining power of suppliers

Exhibit 13: Threat of new entrants

Exhibit 14: Threat of substitutes

Exhibit 15: Threat of rivalry

Exhibit 16: Market condition – Five forces 2018

Exhibit 17: Product – Market share 2018-2023 (%)

Exhibit 18: Comparison by product

Exhibit 19: Instruments – Market size and forecast 2018-2023 ($ millions)

Exhibit 20: Instruments – Year-over-year growth 2019-2023 (%)

Exhibit 21: Consumables – Market size and forecast 2018-2023 ($ millions)

Exhibit 22: Consumables – Year-over-year growth 2019-2023 (%)

Exhibit 23: Market opportunity by product

Exhibit 24: Customer landscape

Exhibit 25: Market share by geography 2018-2023 (%)

Exhibit 26: Geographic comparison

Exhibit 27: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 28: North America – Year-over-year growth 2019-2023 (%)

Exhibit 29: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 30: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 31: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 32: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 33: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 34: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 35: Key leading countries

Exhibit 36: Market opportunity

Exhibit 37: Impact of drivers and challenges

Exhibit 38: Vendor landscape

Exhibit 39: Landscape disruption

Exhibit 40: Vendors covered

Exhibit 41: Vendor classification

Exhibit 42: Market positioning of vendors

Exhibit 43: Abbott – Vendor overview

Exhibit 44: Abbott – Business segments

Exhibit 45: Abbott – Organizational developments

Exhibit 46: Abbott – Geographic focus

Exhibit 47: Abbott – Segment focus

Exhibit 48: Abbott – Key offerings

Exhibit 49: Bio-Rad Laboratories Inc. – Vendor overview

Exhibit 50: Bio-Rad Laboratories Inc. – Product segments

Exhibit 51: Bio-Rad Laboratories Inc. – Organizational developments

Exhibit 52: Bio-Rad Laboratories Inc. – Geographic focus

Exhibit 53: Bio-Rad Laboratories Inc. – Segment focus

Exhibit 54: Bio-Rad Laboratories Inc. – Key offerings

Exhibit 55: Danaher Corp. – Vendor overview

Exhibit 56: Danaher Corp. – Business segments

Exhibit 57: Danaher Corp. – Organizational developments

Exhibit 58: Danaher Corp. – Geographic focus

Exhibit 59: Danaher Corp. – Segment focus

Exhibit 60: Danaher Corp. – Key offerings

Exhibit 61: F. Hoffmann-La Roche Ltd – Vendor overview

Exhibit 62: F. Hoffmann-La Roche Ltd – Product segments

Exhibit 63: F. Hoffmann-La Roche Ltd – Organizational developments

Exhibit 64: F. Hoffmann-La Roche Ltd – Geographic focus

Exhibit 65: F. Hoffmann-La Roche Ltd – Segment focus

Exhibit 66: F. Hoffmann-La Roche Ltd – Key offerings

Exhibit 67: Thermo Fisher Scientific Inc. – Vendor overview

Exhibit 68: Thermo Fisher Scientific Inc. – Business segments

Exhibit 69: Thermo Fisher Scientific Inc. – Organizational developments

Exhibit 70: Thermo Fisher Scientific Inc. – Geographic focus

Exhibit 71: Thermo Fisher Scientific Inc. – Segment focus

Exhibit 72: Thermo Fisher Scientific Inc. – Key offerings

Exhibit 73: Validation techniques employed for market sizing

Exhibit 74: Definition of market positioning of vendors



【掲載企業】

Abbott、Bio-Rad Laboratories Inc.、Danaher Corp.、F. Hoffmann-La Roche Ltd、Thermo Fisher Scientific Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[薬物乱用検査の世界市場予測・分析:製品別・地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆